Business Context and Reporting Period
This Form 8-K was filed by McKesson Corporation on January 15, 2014, reporting events occurring on January 9, 2014. The filing concerns the acquisition of Celesio AG, a German pharmaceutical wholesaler, involving McKesson, its subsidiary Dragonfly GmbH & Co. KGaA, and Franz Haniel & Cie. GmbH.
Key Financial Metrics and Transaction Details
- Share Purchase Price: Increased from €23.00 to €23.50 per share of Celesio AG.
- Convertible Bond Offer Prices:
- 2014 Bond (€50,000 principal): Increased to €54,273.00 per bond.
- 2018 Bond (€100,000 principal): Increased to €123,424.00 per bond.
- Transaction Status: The voluntary public tender offers for shares and bonds expired on January 9, 2014.
- Outcome: On January 13, 2014, McKesson announced the tender offers failed to meet minimum acceptance conditions.
Material Changes and Agreements
On January 9, 2014, the parties executed a "Second Amendment" to the Share Purchase Agreement (SPA) originally dated October 24, 2013. Key changes included:
- Increasing the purchase price per share to €23.50.
- Deleting Section 3.2 of the SPA, resulting in Haniel waiving its right to participate in any further price increases.
- A prior "First Amendment" on December 19, 2013, made immaterial technical changes to the settlement procedure.
Outlook, Risks, and Management Commentary
The primary risk disclosed is the failure of the tender offers to secure the necessary minimum acceptance levels, effectively halting the immediate acquisition process as structured. The filing notes that the information provided in Item 7.01 is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act. No specific financial guidance or liquidity metrics for McKesson's ongoing operations are provided in this specific filing.
Investor Verification Checklist
- Verify the current status of the Celesio AG acquisition following the failed tender offer.
- Review the full text of the Second Amendment (Exhibit 10.2) for any remaining conditions precedent.
- Confirm if McKesson intends to restructure the offer or pursue alternative acquisition strategies.
- Check subsequent filings for updates on the relationship with Franz Haniel & Cie. GmbH.